CD8A and neoplasm: The intranodal route of vaccination with DNA, RNA or DC loaded with tumor antigenic peptides or tumor lysates, has been shown to be superior to other routes in eliciting CD8+ T cell responses in both preclinical and clinical settings34, 35, 36, 37.